Nitrobenzindoles and their use in cancer therapy
US7718688B2 · kind B2 · utility
7Cited by
0References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 21, 2005 |
| Grant date | May 18, 2010 |
| Priority date | — |
| Expiry date | Aug 22, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/65583
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates generally to nitro-1,2-dihydro-3H-benzo[e]indoles and related analogues, to their preparation, and to their use as hypoxia-selective drugs and radiosensitizers for cancer therapy, both alone or in combination with radiation and/or other anticancer drugs.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.